The central offices and administrative staff of the Vanderbilt Center for Neuroscience Drug Discovery (VCNDD) will house the Administrative Core. The Administrative Core will provide central administrative support to the Vanderbilt NCDDG. This includes financial management of the NCDDG, including grants management, progress reports, personnel appointments, service contracts, and supply acquisition. In addition, one of the most critical functions of the administrative core will be managing and ensuring effective communication between each of the organizational units within the NCDDG and with NIH. This includes managing capabilities for data sharing, organization for all NCDDG meetings, travel arrangements for face to face meetings with team members, collaborators, advisors, and NIH staff. The administrative core will also coordinate practical aspects of program, including project and data management, transfer of compounds and will monitor and manage regulatory compliance.

Public Health Relevance

The Administrative Core will play a key role in financial management of the NCDDG, scheduling and facilitating meetings to allow fluid communication between each of the investigators and with NIH, and monitoring and managing regulatory compliance.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Program--Cooperative Agreements (U19)
Project #
5U19MH106839-02
Application #
9140075
Study Section
Special Emphasis Panel (ZMH1-ERB-C)
Project Start
Project End
Budget Start
2016-07-01
Budget End
2017-06-30
Support Year
2
Fiscal Year
2016
Total Cost
$76,835
Indirect Cost
$27,896
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37240
Berizzi, Alice E; Bender, Aaron M; Lindsley, Craig W et al. (2018) Structure-Activity Relationships of Pan-G?q/11 Coupled Muscarinic Acetylcholine Receptor Positive Allosteric Modulators. ACS Chem Neurosci 9:1818-1828
Bender, Aaron M; Cho, Hyekyung P; Nance, Kellie D et al. (2018) Discovery and Optimization of Potent and CNS Penetrant M5-Preferring Positive Allosteric Modulators Derived from a Novel, Chiral N-(Indanyl)piperidine Amide Scaffold. ACS Chem Neurosci 9:1572-1581
Rook, Jerri M; Bertron, Jeanette L; Cho, Hyekyung P et al. (2018) A Novel M1 PAM VU0486846 Exerts Efficacy in Cognition Models without Displaying Agonist Activity or Cholinergic Toxicity. ACS Chem Neurosci 9:2274-2285
Moran, Sean P; Dickerson, Jonathan W; Cho, Hyekyung P et al. (2018) M1-positive allosteric modulators lacking agonist activity provide the optimal profile for enhancing cognition. Neuropsychopharmacology 43:1763-1771
Rook, Jerri M; Abe, Masahito; Cho, Hyekyung P et al. (2017) Diverse Effects on M1 Signaling and Adverse Effect Liability within a Series of M1 Ago-PAMs. ACS Chem Neurosci 8:866-883
Lindsley, Craig W; Emmitte, Kyle A; Hopkins, Corey R et al. (2016) Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery: Recent Advances with Metabotropic Glutamate Receptors. Chem Rev 116:6707-41
Panarese, Joseph D; Cho, Hykeyung P; Adams, Jeffrey J et al. (2016) Further optimization of the M1 PAM VU0453595: Discovery of novel heterobicyclic core motifs with improved CNS penetration. Bioorg Med Chem Lett 26:3822-5